购物车
- 全部删除
- 您的购物车当前为空
PKI-402 是一种有效的 PI3K 和 mTOR 抑制剂,对 PI3Kα, mTOR, PI3Kβ, PI3Kδ 和 PI3Kγ 抑制的IC50 分别为 2, 3, 7, 14 和 16 nM。
为众多的药物研发团队赋能,
让新药发现更简单!
PKI-402 是一种有效的 PI3K 和 mTOR 抑制剂,对 PI3Kα, mTOR, PI3Kβ, PI3Kδ 和 PI3Kγ 抑制的IC50 分别为 2, 3, 7, 14 和 16 nM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 286 | 现货 | |
5 mg | ¥ 666 | 现货 | |
10 mg | ¥ 1,070 | 现货 | |
25 mg | ¥ 2,150 | 现货 | |
50 mg | ¥ 3,270 | 现货 | |
100 mg | ¥ 4,590 | 现货 | |
500 mg | 询价 | 现货 |
产品描述 | PKI-402 is a potent PI3K and mTOR inhibitor. PKI-402 inhibits PI3Kα, mTOR, PI3Kβ, PI3Kδ and PI3Kγ with IC50s of 2, 3, 7, 14 and 16 nM, respectively. |
体外活性 | PKI-402 causes in vitro growth inhibition of human tumor cell lines derived from a diverse set of human tumor tissues, including breast, brain (glioma), pancreas, and non-small cell lung cancer (NSCLC) tissues[1]. |
体内活性 | PKI-402 displays antitumor activity (i.v. route) in breast [MDA-MB-361: Her2+ and PIK3CA (E545K)], glioma (U87MG and PTEN), and NSCLC (A549; K-Ras and STK11) xenograft models. PKI-402 causes regression in the MDA-MB-361 xenograft model. |
分子量 | 570.65 |
分子式 | C29H34N10O3 |
CAS No. | 1173204-81-3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||
溶解度信息 | DMSO: 5 mg/mL (8.76 mM), Sonication is recommended. | |||||||||||||||
溶液配制表 | ||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.